Literature DB >> 31268109

Improved synthesis of the bifunctional chelator p-SCN-Bn-HOPO.

N V S Dinesh K Bhupathiraju1, Ali Younes1, Minhua Cao1, Jafar Ali1, Huseyin T Cicek1, Kathryn M Tully2, Shashikanth Ponnala3, John W Babich3, Melissa A Deri4, Jason S Lewis2, Lynn C Francesconi5, Charles Michael Drain5.   

Abstract

The bifunctional ligand p-SCN-Bn-HOPO, which has four 1,2-hydroxypyridinone groups on a spermine backbone with an isothiocyanate linker, has been shown to be an efficient and stable chelator for Zr(iv) and, more importantly, the radioisotope 89Zr for use in radiolabeling antibodies for positron emission tomography (PET) imaging. Previous studies of 89Zr-HOPO-trastuzumab in mice showed low background, good tumor to organ contrast, and very low bone uptake which show p-SCN-Bn-HOPO to be an important next-generation bifunctional chelator for radioimmunoPET imaging with 89Zr. However, the reported synthesis of p-SCN-Bn-HOPO involves nine steps and multiple HPLC purifications with an overall yield of about 1.4%. Herein we report an improved and efficient synthesis of p-SCN-Bn-HOPO in four steps with 14.3% overall yield which will improve its availability for further biological studies and wider application in PET imaging. The new synthetic route also allows variation in linker length and chemistries which may be helpful in modifying in vivo clearance behaviors of future agents.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31268109      PMCID: PMC6640124          DOI: 10.1039/c9ob01068h

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  13 in total

1.  Macrocycle-Based Hydroxamate Ligands for Complexation and Immunoconjugation of 89Zirconium for Positron Emission Tomography (PET) Imaging.

Authors:  Eszter Boros; Jason P Holland; Nathaniel Kenton; Nicholas Rotile; Peter Caravan
Journal:  Chempluschem       Date:  2016-01-25       Impact factor: 2.863

Review 2.  PET imaging with ⁸⁹Zr: from radiochemistry to the clinic.

Authors:  Melissa A Deri; Brian M Zeglis; Lynn C Francesconi; Jason S Lewis
Journal:  Nucl Med Biol       Date:  2012-09-19       Impact factor: 2.408

3.  Design, synthesis and evaluation of novel bifunctional tetrahydroxamate chelators for PET imaging of 89Zr-labeled antibodies.

Authors:  Julie Rousseau; Zhengxing Zhang; Gemma M Dias; Chengcheng Zhang; Nadine Colpo; François Bénard; Kuo-Shyan Lin
Journal:  Bioorg Med Chem Lett       Date:  2017-01-18       Impact factor: 2.823

4.  Investigation of Zr(IV) and 89Zr(IV) complexation with hydroxamates: progress towards designing a better chelator than desferrioxamine B for immuno-PET imaging.

Authors:  François Guérard; Yong-Sok Lee; Raphaël Tripier; Lawrence P Szajek; Jeffrey R Deschamps; Martin W Brechbiel
Journal:  Chem Commun (Camb)       Date:  2012-12-19       Impact factor: 6.222

5.  Rational design, synthesis, and evaluation of tetrahydroxamic acid chelators for stable complexation of zirconium(IV).

Authors:  François Guérard; Yong-Sok Lee; Martin W Brechbiel
Journal:  Chemistry       Date:  2014-04-16       Impact factor: 5.236

6.  p-SCN-Bn-HOPO: A Superior Bifunctional Chelator for (89)Zr ImmunoPET.

Authors:  Melissa A Deri; Shashikanth Ponnala; Paul Kozlowski; Benjamin P Burton-Pye; Huseyin T Cicek; Chunhua Hu; Jason S Lewis; Lynn C Francesconi
Journal:  Bioconjug Chem       Date:  2015-11-25       Impact factor: 4.774

7.  Novel Bifunctional Cyclic Chelator for (89)Zr Labeling-Radiolabeling and Targeting Properties of RGD Conjugates.

Authors:  Chuangyan Zhai; Dominik Summer; Christine Rangger; Gerben M Franssen; Peter Laverman; Hubertus Haas; Milos Petrik; Roland Haubner; Clemens Decristoforo
Journal:  Mol Pharm       Date:  2015-05-19       Impact factor: 4.939

8.  p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging.

Authors:  Lars R Perk; Maria J W D Vosjan; Gerard W M Visser; Marianne Budde; Paul Jurek; Garry E Kiefer; Guus A M S van Dongen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-18       Impact factor: 9.236

9.  Alternative chelator for ⁸⁹Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO).

Authors:  Melissa A Deri; Shashikanth Ponnala; Brian M Zeglis; Gabor Pohl; J J Dannenberg; Jason S Lewis; Lynn C Francesconi
Journal:  J Med Chem       Date:  2014-05-19       Impact factor: 7.446

10.  Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89Zr-immuno-PET.

Authors:  Danielle J Vugts; Chris Klaver; Claudia Sewing; Alex J Poot; Kevin Adamzek; Seraina Huegli; Cristina Mari; Gerard W M Visser; Ibai E Valverde; Gilles Gasser; Thomas L Mindt; Guus A M S van Dongen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-08-30       Impact factor: 9.236

View more
  3 in total

Review 1.  Hydroxypyridinones as a Very Promising Platform for Targeted Diagnostic and Therapeutic Radiopharmaceuticals.

Authors:  Xu Zhou; Linlin Dong; Langtao Shen
Journal:  Molecules       Date:  2021-11-19       Impact factor: 4.411

2.  State of the Art in Radiolabeling of Antibodies with Common and Uncommon Radiometals for Preclinical and Clinical Immuno-PET.

Authors:  Marion Chomet; Guus A M S van Dongen; Danielle J Vugts
Journal:  Bioconjug Chem       Date:  2021-05-11       Impact factor: 4.774

3.  Side-by-Side Comparison of Five Chelators for 89Zr-Labeling of Biomolecules: Investigation of Chemical/Radiochemical Properties and Complex Stability.

Authors:  Helen Damerow; Ralph Hübner; Benedikt Judmann; Ralf Schirrmacher; Björn Wängler; Gert Fricker; Carmen Wängler
Journal:  Cancers (Basel)       Date:  2021-12-17       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.